Monday June 26th 2017

Posts Tagged ‘officer’

National MS Society Partners with Accelerated Cure Project’s MS Discovery Forum to Drive Research Connections for Progressive MS

National MS Society Partners with Accelerated Cure Project’s MS Discovery Forum to Drive Research Connections for Progressive MS

The National Multiple Sclerosis Society is partnering with the Accelerated Cure Project’s (ACP) Multiple Sclerosis Discovery Forum (MSDF) – an interactive online community and information portal for researchers and clinicians – to develop resources and content [Read More]

Mixed Results from FDA Advisory Panel Meeting To Consider Marketing Approval of Lemtrada™ (alemtuzumab) for Relapsing MS

Mixed Results from FDA Advisory Panel Meeting To Consider Marketing Approval of Lemtrada™ (alemtuzumab) for Relapsing MS

An FDA advisory committee met to discuss the application for marketing approval of Lemtrada as a disease-modifying therapy for people with relapsing forms of MS. [Read More]

National MS Society Commits $19.4 Million in 38 New Research Projects

National MS Society Commits $19.4 Million in 38 New Research Projects

The National MS Society has just launched 38 new MS research projects, with multiyear commitments totaling $19.4 million. This commitment is the latest in the Society’s relentless research effort to find solutions for everyone affected by MS. [Read More]

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]